The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide.
Open accessAbstract
The addition of bacterial lipopolysaccharide (LPS) from Escherichia coli 0111:B4 to human monocyte-macrophages cultured in serum results in suppression of scavenger receptor activity. The present studies were performed to examine if the effect on scavenger receptor activity was mediated by LPS alone or by LPS in association with lipoproteins. Radioiodinated LPS (125I-LPS) was added to human plasma in vitro and to normal and hyperlipidemic rabbit plasma in vitro and in vivo to determine the distribution of 125I-LPS among the lipoprotein classes. It was found that all lipoprotein classes bound LPS in direct proportion to their plasma cholesterol concentration. LPS alone was compared to LPS bound to low density lipoprotein (LDL), high density lipoprotein, or reductively-methylated LDL for their abilities to suppress scavenger receptor activity in monocyte-macrophages in lipoprotein-free serum. Only LPS bound to LDL (LPS-LDL) demonstrated an effect similar to that observed when LPS was added to cells in serum. Either unlabeled LDL or unlabeled LPS-LDL complexes competed with the uptake of 125I-LPS-LDL complexes, which appeared to proceed by receptor-mediated endocytosis. In contrast to the uptake of 125I-LDL, the uptake of 125I-LPS-LDL by cultured monocyte-macrophages was not followed by its hydrolysis and the release of its radioactive degradation products into the medium. The association of LPS with lipoproteins was very stable and appeared to be mediated by a lipid-lipid interaction. We hypothesize that LPS bound to lipoproteins may be transported into the artery wall and may initiate the atherosclerotic reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Cited by
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 786
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
Van Amersfoort, E. S., Van Berkel, T. J. C., & Kuiper, J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.379-414.2003 · Cited by 750
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485
Feingold, K., Staprans, I., Memon, R., Moser, A., Shigenaga, J., Doerrler, W., Dinarello, C., & Grunfeld, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41334-3 · Cited by 346
Horwich, T. B., Hamilton, M. A., MacLellan, W. R., & Fonarow, G. C. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.0804216 · Cited by 337
Harris, H. W., Grunfeld, C., Feingold, K. R., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 320
Role of Infection as a Risk Factor for Atherosclerosis, Myocardial Infarction, and Stroke
Mattila, K. J., Valtonen, V. V., Nieminen, M. S., & Asikainen, S. (1998) · Clinical Infectious Diseases · doi:10.1086/514570 · Cited by 309
Dental infections and coronary atherosclerosis
Mattila, K. J., Valle, M. S., Nieminen, M. S., Valtonen, V. V., & Hietaniemi, K. L. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90263-t · Cited by 308
Interleukin-6 stimulates hepatic triglyceride secretion in rats
Nonogaki, K. (1995) · Endocrinology · doi:10.1210/en.136.5.2143 · Cited by 304
Mesotten, D., Swinnen, J. V., Vanderhoydonc, F., Wouters, P. J., & Van den Berghe, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030760 · Cited by 288
Gutsmann, T., Müller, M., Carroll, S. F., MacKenzie, R. C., Wiese, A., & Seydel, U. (2001) · Infection and Immunity · doi:10.1128/iai.69.11.6942-6950.2001 · Cited by 229
“Furthermore, LBP has been found to mediate LPS transfer to reconstituted high density lipoprotein (HDL) and to low density lipoprotein, attenuating its stimulatory effects (40, 47).”
BackgroundApolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality
Van Oosten, M., Rensen, P. C. N., Van Amersfoort, E. S., Van Eck, M., Van Dam, A.-M., Brevé, J. J. P., Vogel, T., Panet, A., Van Berkel, T. J. C., & Kuiper, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009915200 · Cited by 186
Cai, L., Ji, A., de Beer, F. C., Tannock, L. R., & van der Westhuyzen, D. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31539 · Cited by 167
Neuroinflammation‐induced acceleration of amyloid deposition in the APPV717F transgenic mouse
Qiao, X., Cummins, D. J., & Paul, S. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01666.x · Cited by 119
Rensen, P. C., Oosten, M., Bilt, E., Eck, M., Kuiper, J., & Berkel, T. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119427 · Cited by 113
“VLDL and chylomicrons were able to protect mice and rats against a lethal dose of endotoxin (20, 21), and significantly reduced the serum levels of TNF.”
Background
Metadata
- Authors
- Van Lenten, B. J., Fogelman, A. M., Haberland, M. E., & Edwards, P. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-04
- Volume
- 83
- Issue
- 8
- Pages
- 2704-2708
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2144571843
- Cited by
- 185
- References
- 1
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.